$9.78
4.26% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US45780L1044
Symbol
INGN

Inogen, Inc. Stock price

$9.78
+0.55 5.96% 1M
+0.97 11.01% 6M
+4.29 78.14% YTD
+3.90 66.33% 1Y
-23.78 70.86% 3Y
-66.37 87.16% 5Y
-14.89 60.36% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.40 4.26%
ISIN
US45780L1044
Symbol
INGN
Sector

Key metrics

Market capitalization $232.94m
Enterprise Value $128.84m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.39
P/S ratio (TTM) P/S ratio 0.70
P/B ratio (TTM) P/B ratio 1.26
Revenue growth (TTM) Revenue growth 1.12%
Revenue (TTM) Revenue $331.52m
EBIT (operating result TTM) EBIT $-50.80m
Free Cash Flow (TTM) Free Cash Flow $-12.38m
Cash position $124.25m
EPS (TTM) EPS $-2.25
P/E forward negative
P/S forward 0.71
EV/Sales forward 0.39
Short interest 3.49%
Show more

Is Inogen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Inogen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Inogen, Inc. forecast:

1x Buy
25%
2x Hold
50%
1x Sell
25%

Analyst Opinions

4 Analysts have issued a Inogen, Inc. forecast:

Buy
25%
Hold
50%
Sell
25%

Financial data from Inogen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
332 332
1% 1%
100%
- Direct Costs 174 174
7% 7%
52%
158 158
12% 12%
48%
- Selling and Administrative Expenses 168 168
22% 22%
51%
- Research and Development Expense 19 19
3% 3%
6%
-30 -30
70% 70%
-9%
- Depreciation and Amortization 21 21
11% 11%
6%
EBIT (Operating Income) EBIT -51 -51
39% 39%
-15%
Net Profit -53 -53
60% 60%
-16%

In millions USD.

Don't miss a Thing! We will send you all news about Inogen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inogen, Inc. Stock News

Neutral
Seeking Alpha
16 days ago
Call Start: 17:00 January 1, 0000 5:26 PM ET Inogen, Inc. (NASDAQ:INGN ) Q3 2024 Earnings Conference Call November 7, 2024, 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and CEO Mike Bourque - Chief Financial Officer Conference Call Participants Rohin Patel - JPMorgan Mike Matson - Needham Operator Welcome to Inogen's Third Quarter 2024 Earnings Conf...
Neutral
Business Wire
about one month ago
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #COPD--Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024.
Neutral
Business Wire
about 2 months ago
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #COPD--Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC.
More Inogen, Inc. News

Company Profile

Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Head office United States
CEO Kevin Smith
Employees 834
Founded 2001
Website www.inogen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today